A DNCB-induced increase in CD4+RORγt+ Th17 cell fraction was reversed by DEX administration in the atopic dermatitis model but not a decrease in CD4+FoxP3+ Treg cell fraction (Figure 6C,D). The gene discussed is FOXP3; the disease is atopic eczema.